Presentation is loading. Please wait.

Presentation is loading. Please wait.

U.S. Department of the Interior U.S. Geological Survey Pharmaceuticals in the Environment: What we know and need to know 2009 Symposium on Pharmaceuticals.

Similar presentations


Presentation on theme: "U.S. Department of the Interior U.S. Geological Survey Pharmaceuticals in the Environment: What we know and need to know 2009 Symposium on Pharmaceuticals."— Presentation transcript:

1 U.S. Department of the Interior U.S. Geological Survey Pharmaceuticals in the Environment: What we know and need to know 2009 Symposium on Pharmaceuticals in the Home and Environment Northport, Maine October 18-19, 2009 Herb Buxton USGS Toxic Substances Hydrology Program

2 2 Chemicals of Emerging Environmental Concern: Emerging Contaminants Not Just Pharmaceuticals! Chemicals that: interact in their affect on organisms, & interact in their affect on organisms, & co-occur in the environment. co-occur in the environment.

3 3 Modes of Action with Chemical Interactions Endocrine Disruption (biogenic hormones, synthetic hormones, hormone mimics & blockers) Endocrine Disruption (biogenic hormones, synthetic hormones, hormone mimics & blockers) Antimicrobial Resistance (synthetic antimicrobials, natural antimicrobials, metals, pesticides?) Antimicrobial Resistance (synthetic antimicrobials, natural antimicrobials, metals, pesticides?)

4 4 Emerging Contaminants DetergentsDetergents AntioxidantsAntioxidants Fire retardantsFire retardants DisinfectantsDisinfectants FumigantsFumigants FragrancesFragrances Pesticides/ RepellantsPesticides/ Repellants Industrial Chem’s, HPVsIndustrial Chem’s, HPVs Some MetalsSome Metals Biogenic HormonesBiogenic Hormones PhytoestrogensPhytoestrogens Natural antimicrobialsNatural antimicrobials Natural pesticidesNatural pesticides Degradates/ MetabolitesDegradates/ Metabolites Human & Veterinary PharmaceuticalsHuman & Veterinary Pharmaceuticals

5 5 Framing Research Questions Are Pharm’s entering our environment? Are Pharm’s entering our environment? What are the source pathways, their chemical signatures/loads? What are the source pathways, their chemical signatures/loads? Are there sensitive environmental settings? Are there sensitive environmental settings? Do Pharm’s have adverse ecological health effects? Do Pharm’s have adverse ecological health effects? Do Pharm’s persist to finished drinking water and are they a human health risk? Do Pharm’s persist to finished drinking water and are they a human health risk? How can we minimize their entry to the environment or remove them? How can we minimize their entry to the environment or remove them?

6 6 Are Emerging Contaminants entering our natural environment?

7 7  High density of population and animal production.  Present in water at sub-ppb concentrations  Present in complex mixtures.  Greater levels in streams than wells National Surveys of “Susceptible” Waters Kolpin, et al., 2002; Barnes et al., 2008 Pre. drugs Detergents

8 8 Don’t just look in stream waters! Furlong, et al., 2003

9 9 Measurement Capabilities Clofibric Acid (Buser 1998) Clofibric Acid (Buser 1998) 32 drugs in German WWTPs (Ternes 1998) 32 drugs in German WWTPs (Ternes 1998) 45 drugs in US Rivers (Kolpin et al. 2002) 45 drugs in US Rivers (Kolpin et al. 2002) amphetamines amphetamines antibiotics antibiotics antidepressants (SSRIs) antidepressants (SSRIs) antiphlogistics antiphlogistics antivirals antivirals barbiturates barbiturates beta-blockers beta-blockers Ca channel blocker Ca channel blocker contraceptives contraceptives cytostatics cytostatics fibrates fibrates glucocorticoids glucocorticoids muscle relaxants muscle relaxants opioids opioids

10 10 What are the source pathways to the environment and their chemical signatures/loads?

11 11 WW Treatment PlantsWW Treatment Plants Domestic Septic SystemsDomestic Septic Systems Land ApplicationLand Application Industrial/Commercial DischargesIndustrial/Commercial Discharges LandfillsLandfills Water ReuseWater Reuse Human Source Pathways?

12 12 GrazingGrazing AFOs/CAFOsAFOs/CAFOs Waste lagoonsWaste lagoons Land applicationLand application ProcessingProcessing AquacultureAquaculture PetsPets Animal Source Pathways?

13 13 WWTP Discharges to Streams Complex chemical mixtures.Complex chemical mixtures. Multiple upstream WWTP discharges.Multiple upstream WWTP discharges. Significant % WW in some streams (arid or urbanized watersheds).Significant % WW in some streams (arid or urbanized watersheds).

14 14 Carbon Norm. Concentration (  g/kg,10-40% C) Carbon Norm. Concentration (  g/kg,10-40% C) RangeMedian RangeMedian Carbemazepine 15-1,200 68 Diphenhydramine32-22,000 340 Fluoxetine100-4,700 370 Triclosan 1,170-32,900 10,200 Kinney et al., 2006 Biosolids from 9 sitesBiosolids from 9 sites 53 (of 87) ECs detected53 (of 87) ECs detected 30 to 45 in each biosolid30 to 45 in each biosolid 25 in all samples25 in all samples ECs in Biosolids Destined for Land App

15 15 Septic Systems ECs found in septic wastewaters and adjacent groundwater (Swartz et al., 2006; Carrara et al., 2008) Higher levels in commercial than domestic septics ( restaurants, convenience stores, retail centers, schools, veterinary hospitals ) (Conn et al., 2006)

16 16 Conc. Animal Feeding Operations Manure (kg/day) Human 1.5 Cow 30 Hog 4 Sheep 1.5 Chicken 0.14 Large facilitiesLarge facilities Prophylactic dosesProphylactic doses Antibiotics, growth promoters, estrus modulators, …Antibiotics, growth promoters, estrus modulators, …

17 17 Antibiotics in 46 Swine AFOs Detections (%) Antibiotics in Swine Lagoons Meyer et al., 2003

18 18 Are there sensitive environmental settings?

19 19 Hospital Effluents (Antibiotics) 3 Hospitals in Southeast Queensland, Australia 16 of the 27 antibiotics detected. Watkinson et al., 2009

20 20 Pharm. Manufacturing Facilities Larsson et al., 2007 WWTP near Hyderabad India Receives effluent from 90 bulk drug manufacturers.Receives effluent from 90 bulk drug manufacturers. Samples on consecutive days.Samples on consecutive days. Active IngredientDrug TypeRange (  g/L) Ciprofloxacinantibiotic28,000-31,000 Losartanangiotensin II receptor antagonist2,400-2,500 CetrizineH 1 -receptor antagonist1,300-1,400 MetoprololB 1 -andrenoreceptor antagonist800-950 EnrofloxacinAntibiotic780-900 CitalopramSSRI770-840 Norfloxacinantibiotic390-420 Lomefloxacinantibiotic150-300 Enoxacinantibiotic150-300 Ofloxacin antibiotic150-160

21 21 Hydrologic Events Cedar Rapids, IA Spring Flush 21 herbicides, 27 degradates, 36 antibiotics in 51 Midwest Streams Midwest Floods, Spring ‘08 Scribner et al., 2003

22 22 Animal Waste Lagoon Failure Aug 24, 2009Sept 8, 2009 Sept 14, 2009 Sept 21, 2009 Midwest Headwaters Stream

23 23 Do EC’s have adverse ecological health effects?

24 24 EC Uptake in Organisms Plant Tissue Oxytetracycline in alfalfa (Kong et al., 2007). Oxytetracycline in alfalfa (Kong et al., 2007). Oxytetracycline, flumequine & oxolinic acid in bryophytes (Delepee et al., 2004). Oxytetracycline, flumequine & oxolinic acid in bryophytes (Delepee et al., 2004). Trimethoprim in carrots & lettuce (Boxall et al., 2006). Trimethoprim in carrots & lettuce (Boxall et al., 2006). Sulfamethazine in corn, lettuce, potatoes (Dolliver, et al., 2007). Sulfamethazine in corn, lettuce, potatoes (Dolliver, et al., 2007). Animal Tissue Fluoxetine in bluegill, catfish, carp, crappie (Brooks et al., 2005). Fluoxetine in bluegill, catfish, carp, crappie (Brooks et al., 2005). Gemfibrozil in goldfish (Mimeault et al, 2005). Gemfibrozil in goldfish (Mimeault et al, 2005). Triclosan & Methyl-triclosan in carp (Leiker et al., 2008). Triclosan & Methyl-triclosan in carp (Leiker et al., 2008). Trimethoprim & Triclosan in earthworms (Kinney et al., 2008 ). Trimethoprim & Triclosan in earthworms (Kinney et al., 2008 ).

25 25 Antibiotics: Reduced soil microbial activity at env. concentrations (Costanzo et al., 2005; Thiele-Bruhn and Beck, 2005). Antibiotics: Reduced soil microbial activity at env. concentrations (Costanzo et al., 2005; Thiele-Bruhn and Beck, 2005). Diclofenac (NSAID): Consumption of diclofenac-treated meat caused renal failure in vultures (Oaks et al., 2004). Diclofenac (NSAID): Consumption of diclofenac-treated meat caused renal failure in vultures (Oaks et al., 2004). Ciprofloxacin, triclosan, Tergitol NP 10: shifts in algal community structure (Wilson et al., 2003). Ciprofloxacin, triclosan, Tergitol NP 10: shifts in algal community structure (Wilson et al., 2003). Drug Mixtures 13: Inhibited growth of human embryonic cells at environmental levels (Pomati et al., 2006, 2008). Drug Mixtures 13: Inhibited growth of human embryonic cells at environmental levels (Pomati et al., 2006, 2008). Fluoxetine: Affected reproduction in freshwater molluscs -- water-sediment exchange (Sanchez-Arguello et al., 2009). Fluoxetine: Affected reproduction in freshwater molluscs -- water-sediment exchange (Sanchez-Arguello et al., 2009). Antidepressants: (environmental levels) Affected predator avoidance behavior of larval fathead minnow (McGee et al. 2009). Antidepressants: (environmental levels) Affected predator avoidance behavior of larval fathead minnow (McGee et al. 2009). 4-nonylphenol: (environmental exposures) Impaired reproductive potential of male fathead minnows. (Schoenfuss et al., 2008). 4-nonylphenol: (environmental exposures) Impaired reproductive potential of male fathead minnows. (Schoenfuss et al., 2008). Alkylphenolethoxylates: (environmental mixtures) Reduced reproductive competence in male fathead minnows (Bistodeau et al., 2006). Alkylphenolethoxylates: (environmental mixtures) Reduced reproductive competence in male fathead minnows (Bistodeau et al., 2006). Sewage Sludge: Affected bone homeostasis in sheep (Lind et al., 2009). Sewage Sludge: Affected bone homeostasis in sheep (Lind et al., 2009). Ecological Effects

26 26 Boulder Creek, CO Endocrine Disruption: A Case Study Vajda et al., 2008 <0.8 2.1 1.4 2.9 1.2 17b-Estradiol in stream water, in ng/L Boulder WWTP Low-head Dam

27 27 Estrogenicity of Boulder Effluent & Boulder Creek Vajda et al., 2008 Spring 2005

28 28 Endocrine Effects in Boulder Ck ( White Sucker ) Vajda et al., 2008 Intersex 0% 19% Cellular Abnormalities male femaleIntersex Blood Vitellogenin

29 29 Do EC’s persist to finished drinking water and are they a human health risk?

30 30 Natural Dilution and Degradation DW Sources (Streams) 49 Susceptible Streams 139 Percent Detection National Source Water Survey Focazio et al., 2008

31 31 Benotti et al., 2008 ECs in Finished Drinking Water Conducted by Southern Nevada Water Authority Supported by AWWA Research Fnd. & WateReuse Fnd. Pharm’s PCPs 42 19 18 2.1470 93 510 3 0.82100 0.331.225 15 Max. (ppt) *11 of 20 Pharm’s not detected Detections 18 DW Facilities

32 32 Human Health Risk? Chronic low-level exposure. Chronic low-level exposure. Exposure to chemical mixtures. Exposure to chemical mixtures. Sensitive subpopulations. Sensitive subpopulations. Can we prioritize chemicals systematically for effects studies? Can we prioritize chemicals systematically for effects studies?

33 33 How can we minimize their entry to the environment or remove them?

34 34 Phillips et al., 2008 WWTPs Ability To Reduce ECs A B C D Plant activated sludge trickling filter

35 35 Removal in Treatment, NJ Facility Stackelberg et al., 2004 & 2007 Raw Water Percent Detection HHCB AHTN Levels Generally Reduced by Treatment with GAC Filters Finished Water Percent Detection HHCB Pharmaceutical/Antibiotic Flame retardant/Plasticizer Fragrance Pesticide Plant/Animal steroid Detergent metabolite PAHs Others

36 36 Thank you! And thanks to the many researchers who provided the information presented. For more info on USGS EC research: http://toxics.usgs.gov


Download ppt "U.S. Department of the Interior U.S. Geological Survey Pharmaceuticals in the Environment: What we know and need to know 2009 Symposium on Pharmaceuticals."

Similar presentations


Ads by Google